Blood coagulation kinetics: High throughput method for real-time reaction monitoring

Thrombosis and Haemostasis

Volumn 92, Issue 4, 2004, Pages 874-882

  Lo, Ken ^a   Diamond, Scott L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Fluorescence; Kinetics; Platelet factor 4; Thrombin

Indexed keywords

ADENOSINE DIPHOSPHATE; BLOOD CLOTTING FACTOR 12A; BLOOD CLOTTING FACTOR 5A; CD18 ANTIGEN; CONVULXIN; FIBRINOGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HISTAMINE; INDOMETACIN; PROCOAGULANT; PROTAMINE SULFATE; PROTEIN ANTIBODY; PROTEINASE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN; THROMBOCYTE FACTOR; THROMBOPLASTIN; TRYPSIN INHIBITOR;

ANALYTIC METHOD; ARTICLE; AUTOMATION; BIOASSAY; BLOOD ANALYSIS; BLOOD CLOTTING; CHEMICAL REACTION; CONTAMINATION; CONTROLLED STUDY; CORN; DILUTION; HIGH THROUGHPUT SCREENING; KINETICS; MONITORING; PRIORITY JOURNAL; PROTEIN PURIFICATION; TIME;

AUTOMATION; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CROTALID VENOMS; DRUG SYNERGISM; HUMANS; KINETICS; LECTINS, C-TYPE; PLATELET FACTOR 4; THROMBIN; THROMBOPLASTIN; TITRIMETRY;

EID: 6344246388     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-03-0154     Document Type: Article

References (30)

1. Eerkes A, Shou WZ, Naidong W. Liquid/liquid extraction using 96-well plate format in conjunction with hydrophilic interaction liquid chromatography - tandem mass spectrometry method for the analysis of fluconazole in human plasma. J Pharm Biomed Anal 2003; 31: 917-28.
2. Xie F, Bruntlett CS, Zhu Y, et al. Good pre-clinical bioanalytical chemistry requires proper sampling from laboratory animals: automation of blood and microdialysis sampling improves the productivity of LC/MSMS. Anal Sci 2003; 19: 479-85.
3. Sugimoto M, Matsui H, Mizuno T, et al. Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions. Blood 2003; 101: 915-20.
4. Klein B, Faridi A, von Tempelhoff GF, et al. A whole blood flow cytometric determination of platelet activation by unfractionated and low molecular weight heparin in vitro. Thromb Res 2003; 108: 291-6.
5. Gosalia DN, Diamond SL. Printing chemical libraries on microarrays for fluid phase nanoliter reactions. Proc Natl Acad Sci U S A 2003; 100: 8721-6.
6. Hockin MF, Jones KC, Everse SJ, et al. A model for the stoichiometric regulation of blood coagulation. JBC 2002; 277: 18322-33.
7. Kuharsky AL, Fogelson AL. Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition. Biophys J 2001; 80: 1050-74.
8. Bungay SD, Gentry PA, Gentry RD. A mathematical model of lipid-mediated thrombin generation. Math Med Biol 2003; 20: 105-29.
9. Doggett TA, Girdhar G, Lawshe A. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val. Blood 2003; 102: 152-60.
10. Laurenzi IJ, Diamond SL. Monte Carlo simulation of the heterotypic aggregation kinetics of platelets and neutrophils. Biophys J 1999; 77: 1733-46.
11. Butenas S, van't Veer C, Mann KG. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. JBC 1997; 272: 21527-33.
12. Van't Veer C, and Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. JBC 1997; 272: 4367-77.
13. Gailani D, Broze GJ. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-12.
14. Brummel-Ziedins KE, Pouliot RL, Mann KG. Thrombin generation: phenotypic quantitation. J Thromb Haemost 2004; 2: 281-8.
15. Butenas S, Brummel KE, Branda RF, et al. Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 2002; 99: 923-30.
16. Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
17. Hemker HC, Giesen PL, Ramjee M, et al. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000; 83: 589-91.
18. Hemker HC, Giesen P, Al Dieri R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002; 32: 249-53.
19. Holmes MB, Schneider DJ, Hayes MG, et al. Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapy. Circulation 2000; 102: 2051-7.
20. Polgár J, Clemetson JM, Kehrel BE, et al.. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. JBC 1997; 272: 13576-83.
21. Camire RM, Kalafatis M, Simioni P, et al. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C. Blood 1998; 91: 2818-29.
22. Tracy PB, Eide LL, Bowie EJ, et al. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982; 60: 59-63.
23. Lloyd JV, Joist JH. Recombinant factor VIIa: a universal hemostatic agent? Curr Hematol Rep 2002; 1: 19-26.
24. Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202.
25. Bruins P, te Velthuis H, Eerenberg-Belmer AJ, et al. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro. Thromb Haemost 2000; 84: 237-43.
26. Ranch U, Nemerson Y. Circulating tissue factor and thrombosis. Curr Opin Hematol 2000; 7: 273-7.
27. Goel MS, Diamond SL. Factor VIIa-mediated tenase function on activated platelets under flow. J Thromb Haemost 2004; 8: 1402-10.
28. Brummel KE, Paradis SG, Butenas S, et al. Thrombin functions during tissue factor-induced blood coagulation. Blood 2002; 100: 148-52.
29. Lowe GD. The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann Periodontol 2001; 6: 1-8.
30. Weitz JI. A novel approach to thrombin inhibition. Thromb Res 2003; 109: S17-22.